Smokefree Pennsylvania sent the following letter to the Senate regarding the lies being told in order to benefit Philip Morris.
As a letter to the Senate this is open source – please reuse as you wish.
Smokefree Pennsylvania
1926 Monongahela Avenue
Pittsburgh, PA 15218
412-351-5880
FAX 351-5881
smokefree@compuserve.com
May 20, 2009
Dear Senator
Many inaccurate and misleading claims were made about the least hazardous tobacco products (smokefree) by Senators Merkley, Brown, Harkin, Dodd and others at yesterday’s markup session, which primarily benefits the deadliest tobacco product (cigarettes) and Philip Morris’ Marlboro empire, as would enactment of S. 982 (a deal negotiated by the cigarette giant and CTFK in 2004). We urge you to support the amendments (below) because they would improve public health.
Reiterating concerns in my May 7 letter, S. 982 will cause the deaths of millions of more cigarette smokers (primarily Marlboro smokers) unless amended to truthfully inform smokers that cigarettes are 100 times deadlier than smokefree tobacco/nicotine products (including dissolvable tobacco lozenges, snus and electronic cigarettes) and to allow smokers access to these less hazardous products. Switching from cigarettes to smokefree tobacco/nicotine alternatives reduces smoker’s health risks nearly as much as quitting all tobacco/nicotine use, and millions of smokers have already sharply reduced their health risks by switching to smokefree alternatives.
Dissolvable smokefree tobacco lozenges are nearly identical to GlaxoSmithKline’s dissolvable nicotine lozenges (marketed for smoking cessation). While some Senators grandstanded yesterday against tobacco products that comprise less than 1% of the market share and/or are no longer on the market, nobody expressed concerns that GSK http://www.commitlozenge.com/Commit.aspx has been marketing nearly identical nicotine lozenges in Cappuccino, Cherry and Mint flavors.
Claims that tobacco companies still target market to youth ignores the facts that youth tobacco use has declined by 50% to 65% (depending upon product and age group) in the past decade, that the Master Settlement Agreement already prohibits tobacco companies from marketing to youth, and that all 50 states already ban tobacco sales to youth under 18. In contrast to claims that S. 982 would protect youth from tobacco marketing (and Senator Brown’s criticism of a cigarette marketed to his 19 year old daughter), S. 982 would do little to further reduce youth tobacco use primarily because it prohibits the FDA from banning tobacco marketing to high school seniors (age 18). The CBO recently estimated that H.R. 1256 (Rep. Waxman’s similar bill approved by the House) would only reduce youth smoking by 11% and adult smoking by 2% during the next DECADE.
Since 1990, Smokefree Pennsylvania has advocated policies to reduce tobacco smoke pollution indoors, increase cigarette taxes, reduce tobacco marketing to youth, preserve civil justice remedies for tobacco victims, expand smoking cessation services, and inform smokers that smokefree tobacco/nicotine products are far less hazardous alternatives to cigarettes.
Sincerely,
William T. Godshall, MPH
Executive Director
- – -
* Amendments to S. 982 (Kennedy FDA tobacco bill) endorsed by Smokefree Pennsylvania because they would benefit public health.
Amendment Purpose
Burr #1 Complete substitute – new HHS office
* Burr #2 Change “public health” standard to “reduce youth tobacco use” standard
* Burr #3 Smokeless tobacco carveout
* Burr #4 Require reductions in tobacco illness and death
* Coburn #1 Internet sales
Coburn #2 No tobacco program, unless existing FDA products are certified safe
* Coburn #3 Including Native American retailers and manufacturers
* Coburn #4 7 year hard sunset
Coburn #5 E-cigarette carveout
Coburn #6 Medical marijuana
* Coburn #7 GAO study on metrics
Coburn #8 If youth smoking increases 3 years in a row, sunset
* Coburn #9 PACT Act
* Enzi #1 Move tobacco regulation to CDC
* Enzi #2 Higher civil penalties for tobacco companies
* Enzi #3 Menthol and health disparities
* Enzi #4 Imminent hazard authority
* Enzi #5 Strike adverse event reporting and require DSMB
Enzi #6 Premium incentive for cessation
Enzi #7 Reissue 1996 rule
* Enzi #8 Indexing user fees in outyears
Enzi #9 Strike findings
* Hagan #1 To ensure that performance standards are based on achievable technology
Hagan #2 No FDA on the farm
Hagan #3 Roll your own
Hagan #4 Definition of small manufacturer
Hagan #5 Testing only in US labs
Hagan #6 Definition of characterizing flavor
Hatch #1 No effect of Act unless FDA gets sufficient funding for major functions
Hatch #2 No effect of Act unless FDA gets sufficient funding for device review
Hatch #3 No effect of Act unless FDA gets sufficient funding for biologics review
Hatch #4 No effect of Act unless FDA gets sufficient funding for the Office of Generic Drugs
Hatch #5 No effect of Act unless FDA gets sufficient funding for drug evaluation and review
Hatch #6 HHS certification for tobacco importation
* Hatch #7 Standard for reduced risk products
Hatch #8 Appropriations trigger – all FDA
Hatch #9 Appropriations trigger – food safety
* Hatch #10 Performance and financial reports
* Hatch #11 Report on impact of program on SCHIP
McCain #1 No use of military TSP as pay for
Merkley/Brown #1 Dissolvable tobacco products
* Murkowski #1 Track and trace for tobacco
Kennedy #1 No implied seal, repeat Enzi warning labels
Kennedy #2 No implied seal of approval
- – -
Phone and fax numbers for Senate HELP Cmte members, and an e-mail address to contact all members of the committee.
Senate HELP Committee Phone Fax
Edward M. Kennedy (D-MA) 202-224-5465 202-224-5128
Chairman
Christopher J. Dodd (D-CT) 202-224-2823 202-224-1083
Tom Harkin (D-IA) 202-224-3254 202-224-9369
Barbara A. Mikulski (D-MD) 202-224-4654 202-224-8858
Jeff Bingaman (D-NM) 202-224-5521 202-224-2852
Patty Murray (D-WA) 202-224-2621 202-224-0238
Jack Reed (D-RI) 202-224-4642 202-224-4680
Bernie Sanders (I-VT) 202-224-5141 202-228-0776
Sherrod Brown (D-OH) 202-224-2315 202-224-6519
Robert P Casey, Jr (D-PA) 202-224-6324 202-228-0604
Kay Hagan (D-NC) 202-224-6342 202-228-2563
Jeff Merkley (D-OR) 202-224-3753 202-228-3997
Michael Enzi (R-WY) 202-224-5375 202-224-6510
Ranking Member
Judd Gregg (R-NH) 202-224-3324 202-224-4952
Lamar Alexander (R-TN) 202-224-4944 202-228-3398
Richard Burr (R-NC) 202-224-3154 202-228-2981
Johnny Isakson (R-GA) 202-224-3643 202-228-0724
John McCain (R-AZ) 202-224-2235 202-228-2862
Lisa Murkowski (R-AK) 202-224-6665 202-224-5301
Orrin G. Hatch (R-UT) 202-224-5251 202-224-6331
Pat Roberts (R-KS) 202-224-4774 202-224-3514
Tom Coburn (R-OK) 202-224-5754 202-224-6008